SPINAL elements

10 mm Box Broach

LUMBAR SPINE IMPLANTS and INSTRUMENTATION Instructions for Use

6 Pages

Spinal Elements, Inc. · 3115 Melrose Dr., Suite 200 Carlsbad, CA 92010 · U.S.A. · 760.607.0121  LUMBAR SPINE IMPLANTS AND INSTRUMENTATION (LUCENT®, LUCENT® TI-BOND®, LUCENT MAGNUM®)  This package insert covers multiple Spinal Elements lumbar spine systems: the Lucent system, the Lucent Ti-Bond system, the Lucent Magnum system, and Manual Surgical Instruments that are used for the implantation of these systems. LUCENT® & LUCENT® TI-BOND® POSTERIOR LUMBAR INTERBODY SYSTEMS AND LUCENT MAGNUM® ANTERIOR INTERBODY SYSTEM  GENERAL INFORMATION Spinal Elements’ Lucent and Lucent Ti-Bond devices are generally box-shaped devices that have various graft windows throughout their geometry. These devices are made from either titanium alloy (Ti-6Al-4V) conforming to ASTM F136 or ISO 5832-3, polyetheretherketone (PEEK-Optima®) conforming to ASTM F2026, or PEEK with a coating of commercially pure titanium conforming to ASTM F1580. All implants are intended for single patient use only and should not be reused (used in additional patients) under any circumstances. Reuse may result in serious injury or death. Components from this system should not be used in conjunction with components from other systems. Spinal Elements’ Lucent Magnum device is generally oval-shaped devices that have various graft windows throughout their geometry. These devices are made from either titanium alloy (Ti-6Al-4V) conforming to ASTM F 136 or ISO 5832-3, polyetheretherketone (PEEK-Optima®) conforming to ASTM F 2026, or PEEK with a coating of commercially pure titanium conforming to ASTM F 1580. All implants are intended for single patient use only and should not be reused (used in additional patients) under any circumstances. Reuse may result in serious injury or death. Components from this system should not be used in conjunction with components from other systems. INDICATIONS Lucent and Lucent Ti-Bond are intervertebral body fusion devices intended for spinal fusion procedures at one or two contiguous levels (L2-S1) in skeletally mature patients with degenerative disc disease (DDD). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved levels. These patients may have had a previous non-fusion spinal surgery at the involved spinal level(s). These devices are intended to be used with supplemental spinal fixation systems that have been cleared for use in the lumbosacral spine (i.e., posterior pedicle screw and rod systems, anterior plate systems, and anterior screw and rod systems). These devices are intended to be used with autograft or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft. Patients must have undergone a regimen of at least six (6) months non-operative treatment prior to being treated with these devices. CONTRAINDICATIONS 1. Patients with known or probable intolerance to the materials used in the manufacture of this device. 2. Patients with infection, inflammation, fever, tumors, elevated white blood count, obesity, pregnancy, mental illness and other medical conditions which would prohibit beneficial surgical outcome. 3. Patients resistant to following post-operative restrictions on movement especially in athletic and occupational activities. 4. Use with components from other systems. 5. Grossly distorted anatomy caused by congenital abnormalities. 6. Any patient that has had prior fusion surgery at the levels to be treated. 7. Any other medical or surgical condition which would preclude the potential benefit of spinal implant surgery. 8. Rapid joint disease, bone absorption, osteopenia. Osteoporosis is a relative contraindication since this condition may limit the degree of obtainable correction, stabilization, and/or the amount of mechanical fixation. 9. Any case where the implant components selected for use would be too large or too small to achieve a successful result. 10. Any patient having inadequate tissue coverage over the operative site or inadequate bone stock or quality. 11. Any patient in which implant utilization would interfere with anatomical structures or expected physiological performance. INS-LCG  Page 1 of 6  Rev. 20210630
File Type: PDF
File Size: 263 KB
File Name: SPINAL elements - INS-LCG - LUMBAR SPINE IMPLANTS and INSTRUMENTATION Instructions for Use - 2021-06.pdf

By clicking Download you are confirming this is the correct document for your purposes
and that you agree to our Terms & Conditions